EYPT NASDAQ
EyePoint Pharmaceuticals, Inc.
1W: -10.2%
1M: -32.1%
3M: -77.5%
YTD: -81.4%
1Y: -74.8%
3Y: -60.2%
5Y: -72.3%
$3.25
+0.02 (+0.62%)
Weekly Expected Move ±13.3%
$2
$3
$3
$4
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$3M
Revenue
-94.6% YoY
$-307M
Net Income
-74.8% YoY
$-271M
Free Cash Flow
-39.8% YoY
100.0%
Gross Margin
-19207.1%
Op. Margin
-18633.1%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-148.7%
ROA-115.9%
ROIC-3014.8%
Valuation
P/E-0.9
P/B1.7
EV/EBITDA-3.7
Leverage
Debt/Equity0.13
Current Ratio4.50
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z0.62
Beneish M-5.86